Two of the world’s leading payment processing companies have joined forces to launch a new Visa issuing business in the Asia-Pacific region with Australian fintech company Novatti Group (ASX: NOV) partnering with Decta, a leading payments processor in Europe. The partnership leverages two of the company’s core strengths with Novatti holding a Visa Principal Issuer
Read More
Artificial intelligence company SenSen Networks (ASX: SNS) is poised to play a key role in the City of Las Vegas’ plans to become a smart city by 2025 having won a $2.5 million contract to provide the city with AI smart city software, SenSen’s first in the United States. The contract will see SenSen rollout
Read More
Usually referred to in the same breath as health, “wellness” is an amorphous term but that hasn’t stopped investors from flocking to listed exposures to trendy sectors such as organics, artificial meat, probiotics, vitamins and health supplements. Strictly speaking, wellness is not a defined ASX sector and often overlaps the agricultural, biotech, nutrition and health
Read More
Already facilitating 2 million medical appointments between medical professionals and patients, health tech company 1st Group (ASX: 1ST) is set to significantly grow its network with the launch of telehealthclinics.com.au – a dedicated site for booking medical appointments to be conducted via teleconference. Whilst COVID-19 has significantly heightened public interest in telehealth, 1st Group has
Read More
Under new management, medtech company Respiri (ASX: RSH) is poised to enter the lucrative SaaS revenue market by leveraging their asthma screening device to partner with Phenix Healthcare, whose patients will be able to monitor their condition using Respiri’s wheezo device. The agreement will give Phenix Healthcare’s patients diagnosed with asthma an option to monitor
Read More
Biotech company Genetic Signatures (ASX: GSS) is poised to play a major role in flattening the curve of coronavirus cases in Australia after the Therapeutics Goods Association (TGA) approved their SARS-CoV-2 Detection Kit for sale in Australia. Regulatory approval in Australia follows authorisation which was granted in Europe 10 days ago with Genetic Signatures able
Read More
